Clinical trials for Epithelial tumor of the appendix
11 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT06513065Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)University of Southampton · PI: Faheez Mohamed, MBChB, MD, FRCS
- RECRUITINGPhase 2NCT06800391Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei PatientsFondazione IRCCS Istituto Nazionale dei Tumori, Milano · PI: Alessandra Raimondi, MD
- RECRUITINGNCT05734430Genetics of Appendix Cancer StudyAndreana Holowatyj, PhD, MSCI · PI: Andreana N Holowatyj, PhD, MSCI
- ACTIVE NOT RECRUITINGN/ANCT05623787Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal NeoplasmsLaval University · PI: Alexandre Brind'Amour, MD
- RECRUITINGN/ANCT04024917Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal CarcinosisInstitut du Cancer de Montpellier - Val d'Aurelle · PI: Estelle Guerdoux-Ninot, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04902872Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCybrexa Therapeutics
- ACTIVE NOT RECRUITINGPhase 2NCT03074513Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsM.D. Anderson Cancer Center · PI: Kanwal P Raghav, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02387203Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal OriginMercy Medical Center · PI: Armando Sardi, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT01815359ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal MetastasisMemorial Sloan Kettering Cancer Center · PI: Garrett Nash, MD, MPH
- RECRUITINGNCT01617382Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was PerformedUniversitaire Ziekenhuizen KU Leuven · PI: André JL D'Hoore, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT01061515Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal CancerWashington University School of Medicine · PI: Benjamin Tan, M.D.